ScholarIQanswers from OpenAlex & ORCID
Erich Bluhmki
ResearcherPublications, citations & collaboration network
Erich Bluhmki is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Erich Bluhmki have?
ScholarIQindexed works
Erich Bluhmki has 110 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Erich Bluhmki have?
ScholarIQcitation count
Erich Bluhmki has 44,027 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Erich Bluhmki?
ScholarIQh-index
Erich Bluhmki has an h-index of 52 in OpenAlex.
What is the i10-index of Erich Bluhmki?
ScholarIQi10-index
Erich Bluhmki has an i10-index of 86 in OpenAlex.
What is the ORCID of Erich Bluhmki?
ScholarIQorcid
The ORCID for Erich Bluhmki is on the source record.
What is the OpenAlex record for Erich Bluhmki?
ScholarIQopenalex
The OpenAlex for Erich Bluhmki is on the source record.
What are the most-cited papers on Erich Bluhmki?
ScholarIQmost cited works
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J. Woerle, Uli C. Broedl, Silvio E. Inzucchi
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson, Kennedy R. Lees, Patrick D. Lyden, Lisa Blackwell, Gregory W. Albers, Erich Bluhmki, Thomas Brott, Geoff Cohen, Stephen C. Davis, Geoffrey A. Donnan, James C. Grotta, George Howard, Markku Kaste, Masatoshi Koga, Ruediger von Kummer, Maarten G. Lansberg, Richard I. Lindley, Gordon Murray, Jean‐Marc Olivot, Mark Parsons, Barbara C. Tilley, Danilo Toni, Ḱazunori Toyoda, Nils Wahlgren, Joanna M. Wardlaw, William Whiteley, Gregory J. del Zoppo, Colin Baigent, Peter Sandercock, Werner Hacke
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi, Bernard Zinman, David Fitchett, Christoph Wanner, Ele Ferrannini, Martin Schumacher, Claudia Schmoor, Kristin Ohneberg, Odd Erik Johansen, Jyothis T. George, Stefan Hantel, Erich Bluhmki, John M. Lachin